Clearday, Inc. (CLRD)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | -6.84 Million USD | 32.42% |
| 2021 | -10.13 Million USD | 94.28% |
| 2020 | -177.34 Million USD | -5778.17% |
| 2019 | -3.01 Million USD | 99.56% |
| 2018 | -689 Million USD | 73.76% |
| 2017 | -2.62 Billion USD | -79163.51% |
| 2016 | -3.31 Million USD | -20.04% |
| 2015 | -2.76 Million USD | 99.7% |
| 2014 | -926 Million USD | -240.52% |
| 2013 | 659 Million USD | 207.5% |
| 2012 | -613 Million USD | -30276.61% |
| 2011 | -2.01 Million USD | 5.83% |
| 2010 | -2.14 Million USD | -220.73% |
| 2009 | 1.77 Million USD | 100.08% |
| 2008 | -2.14 Billion USD | -1264.97% |
| 2007 | -157 Million USD | -108.85% |
| 2006 | 1.77 Billion USD | -15.11% |
| 2005 | 2.09 Billion USD | 131.52% |
| 2004 | -6.63 Billion USD | -164.23% |
| 2003 | 10.32 Billion USD | 712.94% |
| 2002 | -1.68 Billion USD | 44.3% |
| 2001 | -3.02 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | -461.71 Thousand USD | 59.38% |
| 2023 Q1 | -1.13 Million USD | 51.8% |
| 2023 Q3 | 102.65 Thousand USD | 122.23% |
| 2022 Q4 | -2.35 Million USD | -69.35% |
| 2022 FY | -6.84 Million USD | 32.42% |
| 2022 Q3 | -1.39 Million USD | -6.97% |
| 2022 Q1 | -1.61 Million USD | 65.61% |
| 2022 Q2 | -1.3 Million USD | 19.18% |
| 2021 Q4 | -4.68 Million USD | -75.68% |
| 2021 FY | -10.13 Million USD | 94.28% |
| 2021 Q1 | -857.92 Thousand USD | 51.54% |
| 2021 Q2 | -1.62 Million USD | -89.19% |
| 2021 Q3 | -2.66 Million USD | -64.28% |
| 2020 Q2 | - USD | 100.0% |
| 2020 Q1 | -6 Million USD | 96.7% |
| 2020 Q4 | -1.77 Million USD | -23.81% |
| 2020 Q3 | -1.42 Million USD | 0.0% |
| 2020 FY | -177.34 Million USD | -5778.17% |
| 2019 Q2 | -876 Million USD | -0.69% |
| 2019 Q4 | -182 Million USD | 76.84% |
| 2019 FY | -3.01 Million USD | 99.56% |
| 2019 Q1 | -870 Million USD | -315.54% |
| 2019 Q3 | -786 Million USD | 10.27% |
| 2018 Q3 | -87 Million USD | -23741.3% |
| 2018 Q1 | -393 Million USD | 75.74% |
| 2018 Q4 | -209.36 Million USD | -140.65% |
| 2018 Q2 | 368 Thousand USD | 100.09% |
| 2018 FY | -689 Million USD | 73.76% |
| 2017 FY | -2.62 Billion USD | -79163.51% |
| 2017 Q2 | - USD | 100.0% |
| 2017 Q1 | -66 Million USD | 96.75% |
| 2017 Q4 | -1.62 Billion USD | 0.0% |
| 2016 FY | -3.31 Million USD | -20.04% |
| 2016 Q3 | -940 Million USD | 2.08% |
| 2016 Q4 | -2.03 Billion USD | -116.22% |
| 2016 Q2 | -960 Million USD | -1471.43% |
| 2016 Q1 | 70 Million USD | 102.86% |
| 2015 Q1 | -700 Million USD | -92.31% |
| 2015 Q3 | -703 Million USD | -13.75% |
| 2015 FY | -2.76 Million USD | 99.7% |
| 2015 Q4 | -2.45 Billion USD | -248.76% |
| 2015 Q2 | -618 Million USD | 11.71% |
| 2014 Q4 | -364 Million USD | -19.74% |
| 2014 Q2 | -277 Million USD | -1557.89% |
| 2014 Q1 | 19 Million USD | -93.29% |
| 2014 FY | -926 Million USD | -240.52% |
| 2014 Q3 | -304 Million USD | -9.75% |
| 2013 Q3 | -61 Million USD | -137.89% |
| 2013 Q4 | 283 Million USD | 563.93% |
| 2013 FY | 659 Million USD | 207.5% |
| 2013 Q2 | 161 Million USD | -41.67% |
| 2013 Q1 | 276 Million USD | 264.29% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | -445 Million USD | 16.13% |
| 2012 Q2 | - USD | 100.0% |
| 2012 FY | -613 Million USD | -30276.61% |
| 2012 Q4 | -168 Million USD | 0.0% |
| 2011 Q3 | 1.56 Million USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 527 Million USD | 105.55% |
| 2011 Q4 | -530.58 Million USD | -34046.32% |
| 2011 FY | -2.01 Million USD | 5.83% |
| 2010 Q1 | 1.02 Billion USD | 110.16% |
| 2010 Q4 | -9.49 Billion USD | 0.0% |
| 2010 FY | -2.14 Million USD | -220.73% |
| 2010 Q3 | - USD | 100.0% |
| 2010 Q2 | -230 Million USD | -122.35% |
| 2009 Q3 | 38 Million USD | 105.72% |
| 2009 Q4 | -10.12 Billion USD | -26740.48% |
| 2009 FY | 1.77 Million USD | 100.08% |
| 2009 Q1 | -7 Million USD | 99.67% |
| 2009 Q2 | -664 Million USD | -9385.71% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | -2.14 Billion USD | 0.0% |
| 2008 FY | -2.14 Billion USD | -1264.97% |
| 2008 Q1 | - USD | -100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q4 | 400 Million USD | 0.0% |
| 2007 FY | -157 Million USD | -108.85% |
| 2007 Q1 | -982 Million USD | -200.82% |
| 2007 Q2 | 425 Million USD | 143.28% |
| 2006 Q2 | 274 Million USD | -72.1% |
| 2006 Q4 | 974 Million USD | 0.0% |
| 2006 FY | 1.77 Billion USD | -15.11% |
| 2006 Q1 | 982 Million USD | 60.72% |
| 2005 Q4 | 611 Million USD | 234.29% |
| 2005 Q3 | -455 Million USD | -125.56% |
| 2005 Q2 | 1.78 Billion USD | 1048.39% |
| 2005 Q1 | 155 Million USD | 102.77% |
| 2005 FY | 2.09 Billion USD | 131.52% |
| 2004 FY | -6.63 Billion USD | -164.23% |
| 2004 Q2 | -478 Million USD | 20.33% |
| 2004 Q3 | 39 Million USD | 108.16% |
| 2004 Q1 | -600 Million USD | -107.6% |
| 2004 Q4 | -5.59 Billion USD | -14446.15% |
| 2003 Q3 | 3.42 Billion USD | 40.39% |
| 2003 Q2 | 2.43 Billion USD | 0.0% |
| 2003 FY | 10.32 Billion USD | 712.94% |
| 2003 Q4 | 7.89 Billion USD | 130.76% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q2 | -725 Million USD | -8.7% |
| 2002 FY | -1.68 Billion USD | 44.3% |
| 2002 Q4 | 112 Million USD | 127.65% |
| 2002 Q3 | -405 Million USD | 44.14% |
| 2002 Q1 | -667 Million USD | 0.0% |
| 2001 FY | -3.02 Billion USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | -1.03 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | 172.887% |
| Arem Pacific Corporation | 239.16 Thousand USD | 2963.999% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | 1061.584% |
| BioCorRx Inc. | 53.17 Thousand USD | 12981.478% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | 791.964% |
| Banyan Corp. | 5 Million USD | 236.891% |
| Dental Patient Care America, Inc. | 3.24 Million USD | 311.127% |
| Quantum Medical Transport, Inc. | 1097.61 USD | 624146.519% |
| Empower Clinics Inc. | 1.96 Million USD | 448.045% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | -56062.652% |
| Selectis Health, Inc. | 5.4 Million USD | 226.677% |
| Ethema Health Corporation | 4.66 Million USD | 246.709% |
| HealthLynked Corp. | 2.34 Million USD | 391.626% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | 200.958% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | 1517.986% |
| Comjoyful International Company | - USD | Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 104.767% |
| MedSmart Group Inc. | -19.03 Thousand USD | -35878.553% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | 9450.22% |
| Nova Leap Health Corp. | 9.76 Million USD | 170.12% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | 2047.773% |
| PAO Group, Inc. | - USD | Infinity% |
| Primemd Inc. | 10.5 Million USD | 165.224% |
| Raffles Medical Group Ltd | 239.4 Million USD | 102.861% |
| Ryman Healthcare Limited | 260.65 Million USD | 102.628% |
| Stem Cell Authority, Ltd. | - USD | Infinity% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | -465.493% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | -11089.044% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | -34147.985% |
| Veltex Corporation | 694.58 Thousand USD | 1086.141% |
| World Financial Holding Group | - USD | Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | 2428.868% |